A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants
CY Wang, KP Hwang, HK Kuo… - The Journal of …, 2022 - Am Soc Clin Investig
Background The Delta and Omicron variants of SARS-CoV-2 are currently responsible for
breakthrough infections due to waning immunity. We report phase I/II trial results of UB-612 …
breakthrough infections due to waning immunity. We report phase I/II trial results of UB-612 …